A Quantitative Framework to Identify and Prioritize Opportunities in Biomedical Product Innovation

Authors:

Abstract
Prioritization and funding for health initiatives, including biomedical innovation, may not consistently target unmet public health needs. Public health leaders and industry funders who rely on select metrics like mortality to inform strategic priorities and funding decisions can potentially overlook important considerations, including the effects of disability, cost of treatment, and health disparities. Furthermore, medical research priorities are frequently determined by expert consensus or stakeholder ranking1,2 and can be influenced by advocacy for or bias against select medical disorders.3 A quantitative framework with comprehensive metrics that leverages latest or currently available data across the health ecosystem can help identify, track, prioritize, and align opportunities in biomedical product innovation to address unmet health needs in communities.4,5

This publication has 20 references indexed in Scilit: